Masp-2 inhibitors and methods of use
US-2025376443-A1 · Dec 11, 2025 · US
being further substituted by carboxyl groups
being further substituted by carboxyl groups · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C335/22 |
| Official title | being further substituted by carboxyl groups |
| Display label | being further substituted by carboxyl groups |
| Total patents | 29 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly growing.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Masp-2 inhibitors and methods of use
US-2025368604-A1 · Dec 4, 2025 · US
Masp-2 inhibitors and methods of use
US-2025129020-A1 · Apr 24, 2025 · US
MASP-2 inhibitors and methods of use
US-12195427-B2 · Jan 14, 2025 · US
Ethyl {[N′-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against Spodoptera littoralis (Boisd.)
US-12180147-B1 · Dec 31, 2024 · US
Ethyl {[N′-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against Spodoptera littoralis (Boisd.)
US-12171233-B1 · Dec 24, 2024 · US
Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
US-12017975-B2 · Jun 25, 2024 · US
Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against Spodoptera littoralis (boisd.)
US-11999684-B1 · Jun 4, 2024 · US
Masp-2 inhibitors and methods of use
US-2023145071-A1 · May 11, 2023 · US
Myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
US-2023134821-A1 · May 4, 2023 · US
MASP-2 inhibitors and methods of use
US-11584714-B2 · Feb 21, 2023 · US
Fungicidal aryl amidines
US-2022220068-A1 · Jul 14, 2022 · US
Myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
US-2022112157-A1 · Apr 14, 2022 · US
Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
US-10927075-B2 · Feb 23, 2021 · US
Process for the preparation of enzalutamide
US-10626091-B2 · Apr 21, 2020 · US
Masp-2 inhibitors and methods of use
US-2019367452-A1 · Dec 5, 2019 · US
Process for the preparation of enzalutamide
US-2019127332-A1 · May 2, 2019 · US
Process for the preparation of Enzalutamide
US-10131636-B2 · Nov 20, 2018 · US
3-aryl propiolonitrile compounds for thiol labeling
US-10131626-B2 · Nov 20, 2018 · US
Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
US-2017362172-A1 · Dec 21, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C335/22?
- CPC C07C335/22 is the Cooperative Patent Classification code for “being further substituted by carboxyl groups.”
- How many patents are filed under CPC C07C335/22 (being further substituted by carboxyl groups)?
- Our database includes 29 publications tagged with this CPC code.
- Is patent activity under CPC C07C335/22 growing?
- Publication counts under this code: 4 in 2024 vs 4 in 2025 (latest complete years).